Clinical Trials
3 trialsNCT06120140 2026-06-05
COCOON
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT02955940 2025-12-17
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
Incyte Corporation
Phase 2 Active not recruiting
NCT02119650 2018-02-13
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Incyte Corporation
Phase 2 Terminated